US 9616090
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
granted A61KA61K2035/124A61K35/12
Quick answer
US patent 9616090 (Gene correction of SCID-related genes in hematopoietic stem and progenitor cells) held by Sangamo Biosciences, Inc. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2035/124, A61K35/12, A61K35/28, A61K35/545